Review Article
Considerations in Women with Hypertension
Abstract
Cardiovascular disease is the most common cause of death in women in the United States, and hypertension is a major contributor to cardiovascular mortality. The incidence of hypertension in women is steadily increasing, paralleling the epidemics of obesity and diabetes. Blood pressure control rates among women are suboptimal, even when secondary causes are identified and treated. There are few high-quality data describing specific hypertension-related outcomes in women. Some data comparing hypertensive women to age-matched men suggest advantages to sex-specific strategies, but further study is needed to determine optimal regimens for women throughout their lives. Pregnancy and menopause present unique, complex challenges in hypertension management.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Yoon PW, Gillespie CD, George MG, et al. Control of hypertension among adults—National Health and Nutrition Examination Survey, United States, 2005–2008. MMWR Morb Mortal Wkly Rep. 2012; 61: 19–25.
2. Ong KL, Tso AW, Lam KS, et al. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008; 51: 1142–1148.
3. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008; 52: 818–827.
4. Pimenta E. Hypertension in women. Hypertens Res. 2012; 35: 148–152.
5. Bateman BT, Shaw KM, Kuklina EV, et al. Hypertension in women of reproductive age in the United States: NHANES 1999–2008. PLoS ONE. 2012; 7: e36171
6. Palatini P, Mos L, Santonastaso M, et al. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J Womens Health. 2011; 20: 1175–1181.
7. Taddei S. Blood pressure through aging and menopause. Climacteric. 2009; 12: 36–40.
8. Martins D, Nelson K, Pan D, et al. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med. 2001; 4: 10–13.
9. Antikainen RL, Jousilahti P, Vanhanen H, et al. Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressure. J Hypertens. 2000; 18: 417–423.
10. Lionakis N, Mendrinos D, Sanidas E, et al. Hypertension in the elderly. World J Cardiol. 2012; 4: 135–147.
11. August P, Oparil S. Hypertension in women. J Clin Endocrinol Metab. 1999; 84: 1862–1866.
12. Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician. 2010; 82: 1471–1478.
13. Stranges S, Dorn JM, Cappuccio FP, et al. A population-based study of reduced sleep duration and hypertension: the strongest association may be in premenopausal women. J Hypertens. 2010; 28: 896–902.
14. Fang J, Wheaton AG, Keenan NL, et al. Association of sleep duration and hypertension among US adults varies by age and sex. Am J Hypertens. 2012; 25: 335–341.
15. Gu Q, Burt VL, Paulose-Ram R, et al. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999–2004. Am J Hypertens. 2008; 21: 789–798.
16. Samad Z, Wang TY, Frazier CG, et al. Closing the gap: treating hypertension in women. Cardiol Rev. 2008; 16: 305–313.
17. Erdine S, Arslan E, Olszanecka A. Hypertension in women—pathophysiological and clinical aspects. Przegl Lek. 2012; 69: 72–75.
18. Fisman EZ, Tenenbaum A, Pines A. Systemic hypertension in postmenopausal women: a clinical approach. Curr Hypertens Rep. 2002; 4: 464–470.
19. Kurth T, Moore SC, Gaziano M, et al. Healthy lifestyle and the risk of stroke in women. Arch Intern Med. 2006; 166: 1403–1409.
20. Zhang Y, Tuomilehto J, Jousilahti P, et al. Lifestyle factors and antihypertensive treatment on the risks of ischemic and hemorrhagic stroke. Hypertension. 2012; 60: 906–912.
21. Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, National High Blood Pressure Education Program. Bethesda, MD: National Institutes of Health; 2004; .NIH Publication No. 04-5230
22. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. Circulation. 2011; 123: 1243–1262.
23. Mafeld S, Vasdev N, Haslam P. Renal denervation for treatment-resistant hypertension. Ther Adv Cardiovasc Dis. 2012; 6: 245–258.
24. Ruilope LM, Schmieder R. Current status of renal denervation in resistant hypertension. J Am Soc Hypertens. 2012; 6: 414–416.
25. Schlaich MP, Straznicky N, Grima M, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens. 2011; 29: 991–996.
26. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008; 51: 960–969.
27. Gluhovschi G, Gluhovschi A, Petrica L, et al. Pregnancy-induced hypertension—a particular pathogenic model. Similarities with other forms of arterial hypertension. Rom J Intern Med. 2012; 50: 71–81.
28. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: chronic hypertension in pregnancy. Obstet Gynecol. 2012; 119: 396–407.
29. Flack JM, Peters R, Mehra VC, et al. Hypertension in special populations. Cardiol Clin. 2002; 20: 303–319.
30. Izumi Y, Matsumoto K, Ozawa Y, et al. Effect of age at menopause on blood pressure in postmenopausal women. Am J Hypertens. 2007; 20: 1045–1050.
31. Nuzzo A, Rossi R, Modena MG. Hypertension alone or related to the metabolic syndrome in postmenopausal women. Expert Rev Cardiovasc Ther. 2010; 8: 1541–1548.
32. Hayes SN, Taler SJ. Hypertension in women: current understanding of gender differences. Mayo Clin Proc. 1998; 73: 157–165.
33. Halm MA, Penque S. Heart failure in women. Prog Cardiovasc Nurs. 2000; 15: 121–133.
34. Okin PM, Gerdts E, Kjeldsen SE, et al. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy. Hypertension. 2008; 52: 100–106.
35. Sweileh WM. Gender differences in pharmacological and clinical associates of kidney disease. A hospital-based study. Med Princ Pract. 2008; 17: 102–107.
36. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med. 1997; 126: 761–767.
37. Jones CA, Naqpal S. An update: women, hypertension and therapeutic efficacy. Can J Cardiol. 2001; 17: 1283–1289.
38. Quan A, Kerlikowske K, Gueyffier F, et al. Efficacy of treating hypertension in women. J Gen Intern Med. 1999; 14: 718–729.
39. Wassertheil-Smoller S, Psaty B, Greenland P, et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA. 2004; 292: 2849–2859.
40. Basu R, Franzini L, Krueger PM, et al. Gender disparities in medical expenditures attributable to hypertension in the United States. Womens Health Issues. 2010; 20: 114–125.
